Purpose To estimate and investigate the global lifetime prevalence and correlates of skin bleaching.
Introduction
Skin bleaching (also known as skin lightening, skin toning, skin whitening, etc.) refers to the cosmetic misuse of toxic agents (e.g., mercurials) or abuse of skin lightening agents (e.g., topical corticosteroids) primarily to change one's normal and natural skin color. Many skin bleaching practitioners report experiencing benefits such as perceived increase in attractiveness, confidence and self-esteem, relief from bodily blemishes, and better appreciation from spouses. [1] [2] [3] Conversely, long-term skin bleaching and the use of toxic and highly potent agents has been associated with various harmful outcomes varying from dyschromia to more worrisome systemic side effects including diabetes and hypertension. [4] [5] [6] [7] [8] As a result of these associated harms, the practice of skin bleaching is a public health concern, 4, 9, 10 and the importation and marketing of skin bleaching products has consequently been banned or is strongly regulated in many African, Asian, European, and North American countries. 10 Besides summarizing available literature on a topic, a metaanalytic review has other advantages in terms of statistical methods for combining results from included studies and presenting overall findings, as well as investigating factors that account for between-study variance through a meta-regression analysis. 11 Some previous reviews have been conducted on the skin bleaching literature. [4] [5] [6] [7] [8] [9] [12] [13] [14] [15] However, with one exception, 8 past reviews have been merely narrative and unsystematic. Further, although several epidemiological investigations have been conducted on skin bleaching practice in various parts of the world, 4, 5, 8, 9, 12, 14 to our knowledge, no previous review has quantified through a systematic and meta-analytic approach the global prevalence of skin bleaching.
The dearth of a systematic and quantitative review on the prevalence of skin bleaching is also inferably related to the 
Methods

Search strategy and inclusion criteria
We conducted a systematic and comprehensive literature search in Google Scholar, ISI Web of Science, ProQuest, PsycNET, and PubMed. The following keywords were used for the searches in ISI Web of Science, PsycNET, and PubMed: "preval* skin bleach*", "preval* skin depigment*", "preval* skin lighten*", and "preval* skin toning". Owing to the generation of a high number of superfluous hits using the above key words, they were merged for the searches in Google Scholar and ProQuest: "preval* skin bleach* depigment* lighten* toning".
A total of 339 hits were identified from the database search.
Also, a total of 68 additional records were identified through searches of related material such as reference lists of literature on skin bleaching and relevant websites. After removing duplicates, 351 records were available for screening. Of this pool of 351 records, 253 were removed after screening their titles and abstracts. Thus, 98 records were accessed for further evaluation. After screening the 98 records for eligibility, 68 were included in the analysis. The key inclusion criteria were that the study/literature: (a) was population or hospital/patient-based, and (b) presented original data on the lifetime prevalence of skin bleaching. No restrictions were made in terms of publication language and type (i.e., peer-reviewed or not). The literature search was conducted from February 23, 2017 , to April 28, 2017 .
We conducted the literature search and selection in line with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) procedure, 16 and the guidelines of the Meta-analysis of Observational Studies in Epidemiology (MOOSE) 17 group. Figure 1 presents the literature search and selection process. 
Data extraction
The first author (DS) independently conducted the literature search and selection of articles based on the aforementioned criteria. Articles published in French were translated using Google Translate (Google Inc.) with a plan for corroboration in case of ambiguity or uncertainty. 18, 19 Using a standardized data extraction form, the following data were extracted from the identified studies and coded: first author name and publication year, data collection period, country and continent/region of research, type of sample, study setting, assessment method, sampling method, sample size (total, male, and female), participants' ages (range, mean, and standard deviation), response rate, and various reported lifetime prevalence of skin bleaching (overall, male, female, agents used, and by specific demographics) (see Table 1 ).
Statistical analysis
Software and computational model
The meta-analysis and meta-regression analysis were conducted using Comprehensive Meta-Analysis 3.0. 20 We used a random-effects model to combine estimates from relevant studies. We preferred a random-effects model as it permits higher external validity or generalizability of findings, and is also recommended when included studies are assumed to represent different populations of studies.
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Estimation of prevalences
We estimate two main types of lifetime prevalences. Population prevalences apply to the general population or sample types.
These are the overall/pooled estimate, sex-specific, world region, sample type, data/study period, assessment method, sampling method, and study quality/risk of bias. On the other hand, skin bleacher-specific prevalences refer to the demographic characteristics of skin bleachers and hence apply specifically to skin bleaching practitioners (agents used, age groups, educational level, relationship/marital status, employment status, and residential area). In order to avoid potential inflation of population prevalences, studies presenting data on purposively sampled skin bleachers (lifetime prevalence %100%) were not included in estimating population prevalences. They were also omitted from the meta-regression analysis. However, we included their relevant data in the estimation of the skin bleacher-specific prevalences.
Assessment of study quality/risk of bias
We assessed study quality or risk of presenting biased prevalence estimates using a quality assessment checklist for prevalence studies. 45 The checklist comprises questions assessing nine characteristics of included studies: (a) sample representativeness, (b) the sampling frame, (c) random selection of sample, (d) nonresponse bias, (e) direct collection of data from participants, (f) operationalization, (g) instrument reliability and validity, (h) instrument consistency, and (i) availability of data for estimation of prevalence. Each question was scored "0" (low risk of bias) or "1" (high risk of bias). Hence, the total score ranged from 0 to 9 and was categorized as follows: high quality/ low risk (0-3), moderate quality/risk (4) (5) (6) , and low quality/high risk (7-9) (see Table 2 ).
Publication bias
We tested for publication bias both visually using the funnel plot and statistically using the trim and fill procedure. 46 Where necessary, we adjusted for publication bias and imputed missing studies using the trim and fill procedure. We also performed 14 separate subgroup analyses for significant subcategories based on the Q-statistic to assess the statistical significance of differences in prevalences between the subgroups using a randomeffects model. Here, we adjusted the alpha level for statistical significance with Bonferroni correction (N subgroup comparisons = 14, Bonferroni P = 0.004).
Meta-regression analysis
We conducted a meta-regression analysis to identify correlates of the overall prevalence estimate. The following variables were included in the meta-regression analysis: region (Africa, Asia, Europe, Middle East, and North America), sample type (community, patients, high school students/adolescents, and tertiary/university students), study period (1970-1979, 1980-1989, 1990-1999, 2000-2009, 2010-2017) , assessment method (dermatological evaluation and testing with or without interviews or questionnaires, interviews only, questionnaires only, both interviews and questionnaires), sampling method (nonrandom and random), the proportion of females in the sample (not provided, ≤50%, 51-75%, and >75%), the proportion of persons aged 30 years or younger in the sample (not provided, ≤50%, 51-75%, and >75%), and study quality/risk of bias (high quality/low risk, moderate quality/risk). With the exception of the proportions of females and those aged 30 years or younger in the sample (where we used the 'not provided' subcategories as reference), we used the subcategory with the highest number of studies as the reference for each of the variables (indicated in Table 4 ). BA, blood analysis; C, current prevalence; DE, dermatological evaluation; F, female; HA, hair analysis; I, interview; IQ, interview with questionnaire; LAC, lactation; L, lifetime prevalence; M, male; m, month; Mn, mean; y, year; NR, non-random; OTC, over-the-counter; P, pregnancy; PolyP, polypharmacy; PrL, pregnancy/lactation; Q, questionnaire; R, random; SD, standard deviation; T, total; TC, topical corticosteroids; U, users; UA, urine analysis; xd, times daily; y, year. studies (lifetime prevalences %100%) were not included in estimating the population prevalences (overall, sex-specific, world region, sample type, data/study period, assessment method, sampling method, and study quality/risk of bias) and the metaregression analysis.
Results
Description of studies
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Assessment of study quality/risk of bias A total of 25 (36.8%) studies were categorized as being of high quality/low risk of bias whereas 43 (63.2%) were categorized as having moderate quality/risk of bias. No study met the criteria of poor quality/high risk of bias (see Table 2 ).
Prevalence estimates, subgroup comparisons, and heterogeneity testing Table 3 
Sex specific
The prevalence for females did not reach statistical significance (imputed: 43.8%, P = 0.707). The prevalence for males after imputing 2 studies (trim and fill procedure) was 35.2%.
World regions
Africa had an estimated prevalence of 27.1% after imputing six studies whereas Asia had a prevalence of 23.1%. The difference between the prevalences for the two regions did not reach statistical significance (Q bet = 1.4, P = 0.241).
Sample type
Patients had a prevalence of 21.3%.
Study/data collection period
Studies using data collected or published between 2010 and 2017 had a prevalence of 26.8%.
Assessment method
Studies using dermatological evaluation and testing in addition to other methods (e.g., interviews, questionnaires, or both) reported a prevalence of 24.9% whereas studies that used only interviews had a prevalence of 22.6%. The difference between the two assessment methods was not significant (Q bet = 0.1,
Sampling method
Studies based on random sampling methods had a prevalence of 29.2% whereas studies based on nonrandom sampling reported a prevalence of 27.0% (Q bet = 1.8, P = 0.176).
Study quality/risk of bias
Studies of high quality/low risk had a prevalence of 29.7% while those of moderate quality had a prevalence of 32.3%
(Q bet = 0.1, P = 0.790).
Agents used
Topical corticosteroids (TC) were the most popular agent (51.8%) followed by mercurials (mercury and its derivatives;
34.4%) (Q bet = 20.8, P < 0.001) and other agents containing caustic substances (e.g. 10% salicylate preparations), glycolic or fruit acids, herbal derivatives, kojic acid, vitamins (e.g. A and C), and other products of unknown composition (32.7%) (TC vs.
other agents: Q bet = 27.5, P < 0.001). The difference between the prevalences of use of mercurials and other agents did not reach statistical significance (Q bet = 1.1, P = 0.298).
Age groups
Persons aged 30 or younger were associated with the highest prevalence (55.9%) followed by those aged 31-49 years (25.9%) (Q bet = 39.8, P < 0.001) and those aged ≥50 years (6.1%) (≤30 vs. ≥50 [Q bet = 54.0, P < 0.001]; 31-49 vs. ≥50
[Q bet = 16.9, P < 0.001]).
Educational level
Individuals with no formal education (illiterates) had a prevalence of 17.8%. Additionally, individuals with only primary school education had a prevalence of 31.6%, whereas tertiary educated persons had a prevalence of 22.8%. However, subgroup comparisons showed that these differences were not significant 
Residential area
Persons resident in urban or semiurban areas (74.9%) were associated with a significantly higher prevalence compared (Q bet = 14.8, P < 0.001) to persons living in rural areas (20.5%).
Correlates of skin bleaching prevalence
Results of the meta-regression analysis are presented in Table 4 . The proportion of female participants was significantly associated with skin bleaching prevalence. Specifically, studies that did not report the proportion of female participants were associated with a lower overall prevalence compared to studies with female participants ranging from 51 to 75%, or more than 75%. Altogether, the predictor variables explained 57.0% of the variance in the overall prevalence estimate.
Discussion
We conducted, to our knowledge, the first ever meta-analysis and meta-regression analysis of the global lifetime prevalence of skin bleaching. The overall lifetime prevalence obtained after imputation (27.7%) provides empirical indication of a high global prevalence of skin bleaching practice, in line with suggestions from previous reviews [4] [5] [6] 14 as well as estimates from fiscal and trend analysis of the skin bleaching market. 55 Even though males reported a high lifetime prevalence (35.2%), the sex difference in terms of lifetime prevalence did not reach statistical significance, suggesting that skin bleaching is a unisex practice.
Additionally, the association of only the proportion of females in study samples with skin bleaching prevalence in the metaregression analysis is consistent with the truism in the field. 4, 5, 56 The prevalence of skin bleaching varied considerably across the globe, with Africa and Asia being the continents characterized by the highest practice in line with evidence from global market analysis, suggesting these regions to be the largest and fastest growing skin bleaching markets. 55 This result may also be a reflection of engrained cultural perceptions about skin color and the increasing use of light-skinned models for cosmetic products targeting black consumers. [57] [58] [59] Although prevalence for the Middle East did not reach statistical significance and there was a paucity of data from Europe, North America, South
America, and Oceania, the broad range of countries presenting empirical evidence of skin bleaching prevalence suggests that the practice of skin bleaching is a global phenomenon. 5, 6, 9, 56 As previously noted, prolonged skin bleaching and the use of toxic and highly potent agents has been associated with various adverse consequences. 4, 5, 8, 12 In line with the above, the high prevalence estimate for patients (21.3%) is reasonable. On the other hand, this cohort may be more likely to suffer from preexisting dermatoses for which skin bleaching agents may be required. In fact, individuals may first seek skin bleaching agents primarily to treat preexisting dermatoses, such as postinflammatory hyperpigmentation in the setting of acne, eczema, and papular urticarial and other inflammatory dermatoses. The misuse of these skin bleaching agents to lighten constitutive skin color may be a secondary phenomenon in some patients.
Indeed, about 70% of the cohort in one study had underlying skin pigmentation disorder. 60 In addition, despite the increasing illegalization and regulation as well as public health campaigns against skin bleaching and its agents in many jurisdictions particularly in recent times, 10,12,15 recent prevalence (2010-2017) of 26.8% is high and should be of concern.
Although self-reports have the advantage of generating data from large populations using ethical and relatively cheap methods, studies relying on self-reports have limitations such as false positive and false negative responses particularly when self-reports are not authenticated, using objective measures. Due to the stigmatization of skin bleaching in some countries, skin bleaching agents are marketed using various nomenclature such as "skin-evening creams, skin lighteners, skin-brighteners, skin-whiteners, skin-toners, fading creams, or fairness creams" (p. 148). 58 Hence, some practitioners do not admit engaging in skin bleaching and use some of the above euphemistic Prevalences of subcategories sharing the same figure ( a or b ) are different (P < 0.004). N, number of studies; p%, prevalence (%); 95% CI, (95% confidence interval). Q, heterogeneity statistic; I 2 , heterogeneity index; n I , number of imputed studies; DET, dermatological evaluation and test. c Range (0-9): high quality/low risk (0-3), moderate quality/risk (4-6), poor quality/high risk (7-9). ***P < 0.001; **P < 0.01; *P < 0.05; ns not significant. nomenclature in denying or rejecting their skin bleaching practice. 2, 58, 61 Thus, self-reports are vulnerable to reporting biases.
In contrast, dermatological evaluation and testing may objectively provide valid prevalence estimates. Nonetheless, our findings show that studies including dermatological evaluation and testing as validation for self-reports (interviews and/or questionnaires) and those using only interviews are associated with similar prevalences.
Many substances were used for skin bleaching, of which topical corticosteroids were the most popular. Besides other previously delineated harms, this should be of concern with the accumulating evidence of topical corticosteroid dependence. 25, [62] [63] [64] Mercurycontaining skin bleaching agents were the second most popular agent despite the fact that such cosmetics are illegal or regulated in many parts of the world. 10, 12 The present finding corroborates growing reports of the availability and use of high mercury-containing bleaching agents. 12, 65 This trend is worrisome considering harms associated with the use of such agents including mercury poisoning, renal dysfunction, and neurological disorders. 8, 66 We also found that a large proportion of skin bleachers (32.7%) resort to the use of other substances including acids, caustics, herbal derivatives, and products of unknown composition with potentially dangerous consequences. This study also provides global evidence of hydroquinone use and the practice of polypharmacy among skin bleaching practitioners although their respective prevalence estimates did not reach statistical significance. Range (0-9): high quality/low risk (0-3), moderate quality/risk (4-6), poor quality/high risk (7-9). *P < 0.001; ns not significant.
Moreover, skin bleaching has been described as an element of the youth culture of persons from largely nonwestern contexts or of darker skin tone. 5, 13, 56, 57 Our findings on age prevalence from the meta-analysis is in line with this perspective. In addition, obtaining social capital such as congeniality, esteem, and status and the chances of finding a spouse or employment are important motives for skin bleaching 2,3,9,67,68 which pertain more strongly to younger than to older individuals. In sum, our findings on educational experience, marriage, employment, and practice during pregnancy show that the practice of skin bleaching transcends academic, relationship/marriage, employment, and pregnancy boundaries.
Also, the present finding associating urban and semiurban residents with a higher prevalence compared to rural residents is in line with expert opinion 69 and other viewpoints 2, 70 . It is tenable that urban and semiurban residents in nonwestern cultural contexts have higher exposure to western images of 'lighter beauty' and skin bleaching advertisements and products and are more exposed to the Internet as well as social media, activities, and festivities. It has been argued that this phenomenon is related to the high skin bleaching prevalence among urban and semiurban residents who aim at meeting 'lighter' standards of beauty and enhancing their perceived appearance at social events. 57, 58, 71 It has also been indicated that rural work such as farming exposes people to ultraviolet radiation with subsequent darkening of skin. Hence, rural-to-urban migrants tend to practice skin bleaching in order to enhance their skin color and disguise their rural origin 68 as a means to avoiding stigmatization and prejudice sometimes targeted at rural-to-urban migrants.
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Strengths and Limitations
Our study represents the first systematic and quantitative examination of the global prevalence of skin bleaching. Contemporarily, findings represent the best empirical basis for policymaking and planning. Other strengths of our study include the comprehensive search, the study's global scope, and the innovative data analysis minimizing the effect of extreme studies and combining both meta-analysis and meta-regression analysis. Nonetheless, our study has some limitations that should be considered when interpreting findings. First, as with all systematic reviews, it is reasonable that methodical limitations associated with included studies and their results may have influenced our results.
Also, most studies sampled persons from nonwestern cultural contexts (Africa, Asia, and the Middle East). Indeed, we did not find sufficient studies for estimation of generalizable prevalences for Europe, North America, Oceania, and South America despite reports of skin bleaching practice in Europe, 38, 74 North America, 44, 75 Oceania, 76, 77 and South America. 78, 79 Additionally, we examined lifetime prevalence which is typically higher than other prevalence estimates (e.g. past year, past month, and current) because of the possibility of abstinence and termination as well as susceptibility to recall bias.
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Conclusions and Future Directions
The results of our study have important implications for healthcare professionals, policymakers, and researchers. We provide evidence of a high global prevalence of skin bleaching transcending various geographic, demographic and socioeconomic boundaries. Hence, the practice of skin bleaching should be an issue of global public health concern. This practice and associated harms may be addressed through the regulation of dangerous skin bleaching products, massive consumer education about complications of skin bleaching, highlighting the benefits of melanin pigmentation against ultraviolet radiation and associated dermatoses, and targeted harm reduction and preventive interventions among others as discussed elsewhere. 5, 8, 9, 15, 82 There is also the need for epidemiological studies in currently 
